Jun. 18, 2022

sudapyridine (WX-081)

oral ATP-synthase inhibitor Ph. I candidate for pulmonary tuberculosis toxicol. risk mitigation from prev. disclosed inhibitor Bioorg. Med. Chem. Lett., Sep 1, 2022 WuXi AppTec, Shanghai, CN

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in